COMPANY

TwinStrand Biosciences

HQ: Seattle, WA source · twinstrandbio.com ↗ · West Coast

Location: Seattle, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

12NIH grants

Timeline

Feb 13, 2025 Grant Government grant — SBIR: $1.99M (annual award, as published), announced Feb 13, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Funding

Last 2 years.

Feb 13, 2025 Government grant — SBIR: $1.99M (annual award, as published), announced Feb 13, 2025. Agency: NIH/NCI. Source: government award database. source ↗

NIH awards 12

Annual award amounts. Total $7.7M.

Aug 15, 2023 NIH award 2R44CA233381-05A1 FY2023: $1,139,103 awarded for that fiscal year; activity R44 (SBIR); PI BICKEL, KELLIE; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Universal Assay f source ↗
Jul 20, 2021 NIH award 5R44ES030642-03 FY2021: $619,680 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Genotoxicity Assay usi source ↗
Jan 13, 2021 NIH award 5R44CA233381-04 FY2021: $859,730 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Universal Assay for Mi source ↗
Aug 20, 2020 NIH award 4R44ES030642-02 FY2020: $874,368 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Genotoxicity Assay usi source ↗
Aug 13, 2020 NIH award 5R44CA221426-04 FY2020: $221,887 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Early Detection of Ovarian Cancer Using source ↗
Dec 23, 2019 NIH award 5R44CA233381-03 FY2020: $690,175 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Universal Assay for Mi source ↗
Sep 5, 2019 NIH award 5R44CA221426-03 FY2019: $954,260 awarded for that fiscal year; activity R44 (SBIR); PI WILLIAMS, LINDSEY N; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Early Detection of Ovarian Cancer source ↗
Jul 11, 2019 NIH award 1R44ES030642-01 FY2019: $224,797 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Genotoxicity Assay usi source ↗
May 2, 2019 NIH award 4R44CA233381-02 FY2019: $690,175 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Universal Assay for Mi source ↗
Sep 14, 2018 NIH award 4R44CA221426-02 FY2018: $823,853 awarded for that fiscal year; activity R44 (SBIR); PI WILLIAMS, LINDSEY N; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Early Detection of Ovarian Cancer source ↗
Jul 16, 2018 NIH award 1R44CA233381-01 FY2018: $299,790 awarded for that fiscal year; activity R44 (SBIR); PI SALK, JESSE J; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Development of a Universal Assay for Mi source ↗
Aug 29, 2017 NIH award 1R44CA221426-01 FY2017: $295,409 awarded for that fiscal year; activity R44 (SBIR); PI WILLIAMS, LINDSEY N; recipient as written: TWINSTRAND BIOSCIENCES, INC., SEATTLE, WA. Early Detection of Ovarian Cancer source ↗